T1	Participants 111 142	growth hormone-deficient adults
T2	Participants 251 295	patients with growth hormone deficiency (GHD
T3	Participants 532 733	PATIENTS AND METHODS 20 adult patients with GHD (eleven male, nine female, mean age 42.5 years) were included in the study and randomized to either GH or placebo in a dose of 0.25 U/kg body weight/week
T4	Participants 735 774	After 6 months all patients received GH
T5	Participants 897 967	The patients were compared to 20 age- und sex-matched healthy controls
